Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17510886 | 0.80 | MAPT (0.32) | MAPTTSHRKDM4EALDH1A1GAA | |
| SCHEMBL6996594 | 0.77 | KDM4E (0.32) | MAPTTSHRKDM4EALDH1A1GAA | |
| SCHEMBL19267441 | 0.77 | HDAC3 (0.33) | — | |
| SCHEMBL19220750 | 0.74 | GPR35 (0.32) | — | |
| SCHEMBL19220736 | 0.73 | — | — | |
| SCHEMBL137867 | 0.73 | GPR35 (0.38) | MAPTTSHRKDM4EALDH1A1GAA | |
| SCHEMBL1997385 | 0.72 | GPR35 (0.35) | — | |
| SCHEMBL14323452 | 0.72 | CYP1A1 (0.39) | MAPTKDM4EALDH1A1GAA | |
| SCHEMBL6999797 | 0.72 | GPR35 (0.56) | MAPTTSHRKDM4EALDH1A1GAA | |
| SCHEMBL19267322 | 0.71 | MAPT (0.34) | MAPTTSHRKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472373-B2 | Thienothiophene/dithienothiophene-triphenylamine/tetraphenylethylene derivatives for organic light emitting diodes | TUBITAK (TR) | 2019-11-12 | — | — | US | disclosed |
| EP-3271364-B1 | THIENOTHIOPHENE/DITHIENOTHIOPHENE - TRIPHENYLAMINE/TETRAPHENYLETHYLENE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | TUBITAK (TR) | 2019-06-12 | — | — | EP | disclosed |
| US-20180093996-A1 | THIENOTHIOPHENE/DITHIENOTHIOPHENE - TRIPHENYLAMINE/TETRAPHENYLETHYLENE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | TUBITAK | 2018-04-05 | — | — | US | disclosed |
| EP-3271364-A1 | THIENOTHIOPHENE/DITHIENOTHIOPHENE - TRIPHENYLAMINE/TETRAPHENYLETHYLENE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | Tubitak (TR) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016132179-A1 | THIENOTHIOPHENE/DITHIENOTHIOPHENE - TRIPHENYLAMINE/TETRAPHENYLETHYLENE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | TUBITAK (TR) | 2016-08-25 | — | — | WO | disclosed |
| US-9310660-B2 | Organic compound and electrochromic element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-04-12 | — | — | US | disclosed |
| EP-2291427-B1 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | SOLVAY USA INC (US) | 2016-03-30 | — | — | EP | disclosed |
| US-20150153624-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2015-06-04 | — | — | US | disclosed |
| US-8906520-B2 | Sulfonated polythiophenes comprising fused ring repeat units | SOLVAY USA, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20110147725-A1 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | PLEXTRONICS, INC. | 2011-06-23 | — | — | US | disclosed |
| EP-2291427-A2 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | Plextronics, Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| WO-2009152165-A2 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | PLEXTRONICS, INC. (US) | 2009-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093996-A1 | THIENOTHIOPHENE/DITHIENOTHIOPHENE - TRIPHENYLAMINE/TETRAPHENYLETHYLENE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES | TST, OCIAD1, TPT1 | MAPT 69/4885TSHR 919/4885KDM4E 2072/4885 |
| US-20150153624-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME | ETV6, H1-0, HCN2 | MAPT 3179/4885TSHR 4186/4885KDM4E 2658/4885 |
| US-10472373-B2 | Thienothiophene/dithienothiophene-triphenylamine/tetraphenylethylene derivatives for organic light emitting diodes | TST, OCIAD1, TPT1 | MAPT 69/4885TSHR 919/4885KDM4E 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.